Oculus Innovative Sciences Reports Revenues of $4.1 Million for Second Quarter of Fiscal 2014, Meeting Guidance of Greater Than $3.6 Million Nov 19, 2013
Oculus Innovative Sciences Announces Fiscal Second Quarter 2014 Financial Results and Conference Call Nov 5, 2013
Oculus Innovative Sciences Reports Revenues of $3.4 Million for First Quarter of Fiscal 2014 Aug 8, 2013
Oculus Innovative Sciences Announces Fiscal First Quarter 2014 Financial Results and Conference Call Jul 31, 2013
Oculus Innovative Sciences Announces Allowance of New Patent in Mexico for Novel Solution for Use in Invasive Surgical Procedures Jul 2, 2013
Oculus Innovative Sciences Reports Revenues of $15.5 Million for Fiscal Year 2013, Product Revenue Up 23 Percent Jun 13, 2013
Oculus Innovative Sciences Announces Two Key Agreements With Company's Subsidiary, Ruthigen, Inc. Jun 6, 2013
Oculus Announces Confidential Submission of Draft Registration Statement for Initial Public Offering to Securities and Exchange Commission by Its Subsidiary Ruthigen, Inc. May 28, 2013
Oculus Innovative Sciences Announces Fiscal Fourth Quarter 2013 Financial Results and Conference Call May 23, 2013
Oculus Innovative Sciences Announces New Regulatory Approvals for Microcyn(R)-Based Antiseptic Products in Panama and El Salvador May 1, 2013
